Novel early cancer detection platform.
Tracing tumour in the blood.
On-chip platform technology enabling the ultrasensitive quantification and discovery of exosomes (and their biomarker cargo) shed by tumours and the cancer micro-environment in the blood.
NPQuantumSense
Platform technology based on nanogap electrodes generating quantum phenomena in biofluids to deliver a novel detection approach for bioactive disease target.
-
Quantum manipulation & sensing in biofluids
-
On-chip format
-
Moore's law scalability
Illustration of nanogap electrodes on chip
Cancer Exosome Targets
Exosomes are the future of early cancer detection.
-
Snapshot of tumour biomarker cargo
-
Contain rare -omics information
-
Influence the tumour microenvironment
Illlustration of exosomes